UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A randomized phase II trial comparing different schedules of nab-paclitaxel (nabP) combined with gemcitabine (GEM) as first line treatment for metastatic pancreatic adenocarcinoma (mPDAC).

Corrie, P; Qian, W; Basu, B; Valle, JW; Falk, S; Iwuji, C; Wasan, HS; ... Jodrell, DI; + view all (2017) A randomized phase II trial comparing different schedules of nab-paclitaxel (nabP) combined with gemcitabine (GEM) as first line treatment for metastatic pancreatic adenocarcinoma (mPDAC). Presented at: 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL.

Full text not available from this repository.
Type: Conference item (UNSPECIFIED)
Title: A randomized phase II trial comparing different schedules of nab-paclitaxel (nabP) combined with gemcitabine (GEM) as first line treatment for metastatic pancreatic adenocarcinoma (mPDAC).
Event: 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Location: Chicago, IL
Dates: 02 June 2017 - 06 June 2017
DOI: 10.1200/JCO.2017.35.15_suppl.4100
Keywords: Science & Technology, Life Sciences & Biomedicine, Oncology
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: http://discovery.ucl.ac.uk/id/eprint/10032581
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item